InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Kastelein Johannes Jacob Pieter. Insider active across 1 company, notably NewAmsterdam Pharma Co N.V.. In total, 8 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €1.7m. History available since 26 March 2025. The latest transaction was disclosed on 20 February 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Kastelein Johannes Jacob Pieter is Chief Scientific Officer at NewAmsterdam Pharma Co N.V. (XNAS). Across 8 filings in total, the 8 sampled filings span from 2024-03-27 to 2026-03-09, with EUR 0 in buys and EUR 1653173 in sells, and the stated transaction nature is Levée d'options.